Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions.
D000818:Animals; D001933:Brain Stem / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003655:Decerebrate State; D003891:Desipramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005473:Fluoxetine / Q000031:analogs & derivatives; D006892:Hydroxydopamines / Q000037:antagonists & inhibitors*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism / Q000502:physiology*; D010647:Phenyl Ethers / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012640:Seizures / Q000188:drug therapy*; D013116:Spinal Cord / Q000378:metabolism
D006892:Hydroxydopamines; D010647:Phenyl Ethers; D011437:Propylamines; D005473:Fluoxetine; C011386:nisoxetine; D003891:Desipramine; D009638:Norepinephrine